Mark Norman Levine - McMaster Experts

Affiliations

Faculty of Health Sciences, McMaster University
Emeritus, Escarpment Cancer Research Institute (ECRI), Faculty of Health Sciences
Member, Centre for Medicinal Cannabis Research (CMCR), Faculty of Health Sciences
Professor Emeritus, Oncology, Faculty of Health Sciences

Scholarly Activity in McMaster Experts

Co-author Network

Scholarly Activity
Research
Contact
View All

selected scholarly activity

chapters
- Chapter 11 Thromboembolic Disease in Cancer. 213-225. 2016
- Thromboembolic Disease in Cancer. 213-225. 2016
- Thrombosis and Cancer. 389-403. 2007
conferences
- Perioperative optimization with nutritional supplements in patients undergoing gastrointestinal surgery for cancer: A randomized, placebo-controlled feasibility clinical trial. Surgery. 670-676. 2022
- LUMINA: A prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T₁N₀ luminal A breast cancer (BC).. Journal of Clinical Oncology. 2022
- Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).. Journal of Clinical Oncology. TPS398-TPS398. 2022
- Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK). Journal of Clinical Oncology. 2022
- Perioperative optimization with nutritional supplements in patients undergoing gastrointestinal surgery for cancer: A randomized, placebo controlled feasibility clinical trial.. Journal of Clinical Oncology. 482-482. 2022
- OPAR: A Multicenter Phase II Randomized Trial of Fractionation Schedules for Once-a-Day Accelerated Partial Breast Irradiation (APBI). International Journal of Radiation Oncology Biology Physics. S6-S6. 2021
- Evaluation of sleep problems and their association with febrile neutropenia, leucopenia and infections in women receiving adjuvant chemotherapy for breast cancer in the Canadian Cancer Trials Group MA.21 trial. Cancer Research. 2021
- Randomized Phase II Trial of Metformin in Combination with Chemoradiotherapy (CRT) in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC); the OCOG-ALMERA trial (NCT02115464). International Journal of Radiation Oncology Biology Physics. S104-S104. 2020
- LBA87 A pragmatic cluster-randomized trial of ambulatory toxicity management in patients receiving adjuvant or neo-adjuvant chemotherapy for early stage breast cancer (AToM). Annals of Oncology. S1214-S1214. 2020
- Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK). Journal of Clinical Oncology. 2020
- Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK).. Journal of Clinical Oncology. TPS761-TPS761. 2020
- Abstract GS4-03: RAPID: A randomized trial of accelerated partial breast irradiation using 3-dimensional conformal radiotherapy (3D-CRT). Cancer Research. 2019
- Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases. The long-term results of a randomized controlled trial (PET-CT Imaging prior to liver resection for colorectal adenocarcinoma metastases).. Journal of Clinical Oncology. 2018
- Anticoagulation Therapy in SELECTeD Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the ‘select-d’ Pilot Trial. Thrombosis Research. S194-S194. 2018
- Basal biomarkers Nestin and INPP4b accurately identify intrinsic breast cancer subtype and predict benefit from anthracycline vs. non-anthracycline based treatment in the CCTG MA. 5 phase III randomized clinical trial. Modern Pathology. 46-46. 2018
- Basal biomarkers Nestin and INPP4b accurately identify intrinsic breast cancer subtype and predict benefit from anthracycline vs. non-anthracycline based treatment in the CCTG MA.5 phase III randomized clinical trial. Laboratory Investigation. 46-46. 2018
- Clinical Significance of the AJCC 8th Edition Prognostic Staging System for Triple Negative Breast Cancer (TNBC). Modern Pathology. 51-52. 2018
- Clinical Significance of the AJCC 8th Edition Prognostic Staging System for Triple Negative Breast Cancer (TNBC). Laboratory Investigation. 51-52. 2018
- Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases: The long-term results of a randomized control trial.. Journal of Clinical Oncology. 2018
- Targeted sequencing in early breast cancer: Identification of novel candidate mutations predictive of anthracycline benefit. Cancer Research. 2018
- Validation that a histone gene signature predicts anthracycline response in early breast cancer. Cancer Research. 2018
- Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism: Results of the Select-D™ Pilot Trial. Blood. 2017
- Incidence of venous thromboembolic events following major pelvic and abdominal surgery for cancer.. Journal of Clinical Oncology. 2017
- Dovitinib in advanced adenoid cystic carcinoma of the salivary glands: Ontario Clinical Oncology Group DOVE trial. Annals of Oncology. vi335-vi335. 2016
- A randomized trial of a shorter radiation fractionation schedule for the treatment of localized prostate cancer.. Journal of Clinical Oncology. 5003-5003. 2016
- Anthracycline-induced cardiotoxicity in patients with early stage breast cancer: The Canadian cancer trials group (NCIC CTG) MA.21 experience.. Journal of Clinical Oncology. 1016-1016. 2016
- PET-CT Compared to No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: The Cost Implications of a Randomized Controlled Trial. Annals of Surgical Oncology. S9-S9. 2016
- PET-CT compared to no PET-CT in the management of potentially resectable colorectal cancer liver metastases: The costs implications of a randomized controlled trial. Journal of Clinical Oncology. 2016
- A Phase II Study of Dovitinib in Previously-Treated Malignant Pleural Mesothelioma: The Ontario Clinical Oncology Group DOVE-M Trial. Journal of Thoracic Oncology. S352-S352. 2015
- Abstract 4346: Prognostic gene signature for intermediate risk prostate cancer. Cancer Research. 4346-4346. 2015
- The role of PET-CT in treatment decision making for women with locally advanced cervical cancer.. Journal of Clinical Oncology. 5523-5523. 2015
- Abstract P2-05-05: A four gene signature predicts anthracycline benefit: Evidence from the BR9601 and MA5 breast cancer trials. Cancer Research. 2015
- Abstract P4-11-06: TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial. Cancer Research. p4-11-06-p4-11-06. 2015
- Lifestyle interventions combined with acupuncture-like transcutaneous electrical nerve stimulation in managing vasomotor symptoms induced by breast cancer treatment: Results of a phase 2 randomized controlled trial. Cancer Research. 2015
- TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial. Cancer Research. 2015
- A phase 1 multicenter clinical trial of alemtuzumab and CHOP chemotherapy for peripheral T-cell lymphomas.. Journal of Clinical Oncology. 8551-8551. 2014
- Population-based evaluation of 21-gene assay in treatment decision making for early breast cancer in Ontario.. Journal of Clinical Oncology. 583-583. 2014
- Prognostic and predictive significance of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.. Journal of Clinical Oncology. 11019-11019. 2014
- Prognostic associations of 25OH vitamin D in NCIC CTG MA.21, a phase III adjuvant RCT of three chemotherapy regimens (EC/T, CEF, AC/T) in high-risk breast cancer (BC).. Journal of Clinical Oncology. 504-504. 2014
- Survival crossover adjustment and cost effectiveness analysis: An empirical and methodological review with application. Value in Health. A202-A202. 2014
- Abstract A124: Characterization of claudin-low breast cancers. Molecular Cancer Research. A124-A124. 2013
- The feasibility, acceptability and safety of Molecular Breast Imaging (MBI) using a breast specific gamma camera and 99mTc-sestamibi in patients with a high risk of breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. S462-S462. 2013
- Randomized phase II placebo-controlled trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone receptor-positive metastatic breast cancer (MBC): OCOG Zamboney study-NCT00811369.. Journal of Clinical Oncology. 2013
- Excite – A New Collaborative Model Of Pre-Market Evaluation Of Health Technologies. Value in Health. A264-A264. 2013
- Analytical Variables That Affect the Prognostic Utility of Ki67 in Invasive Breast Cancer. Modern Pathology. 74A-75A. 2013
- Analytical Variables That Affect the Prognostic Utility of Ki67 in Invasive Breast Cancer. Laboratory Investigation. 74A-75A. 2013
- Abstract P1-13-01: A randomized trial of CEF versus dose dense EC followed by paclitaxel versus AC followed by paclitaxel in women with node positive or high risk node negative breast cancer, NCIC CTG MA.21: Results of the final relapse free survival analysis.. Cancer Research. 2012
- Positron emission tomography/computed tomography (PET/CT) for the diagnosis of recurrent cancer (PETREC): A multicenter, prospective cohort study.. Journal of Clinical Oncology. 2012
- Impact of Survivorship Care Plans (SCP) On Adherence to Guidelines, Health Service Measures, and Patient-reported Outcomes (PRO): Extended Results of a Multicenter Randomized Clinical Trial (RCT) with Breast Cancer Survivors. European Journal of Cancer. S147-S147. 2012
- Workplace-based assessment tools in Canada: a comprehensive, cross-sectional survey of anaesthesiology resident coordinators. British Journal of Anaesthesia. 180-180. 2012
- Claudin-Low Breast Cancer; a Molecular Subtype Associated with Poor Prognosis. Modern Pathology. 34A-34A. 2012
- Claudin-Low Breast Cancer; a Molecular Subtype Associated with Poor Prognosis. Laboratory Investigation. 34A-34A. 2012
- Morphological Characteristics of HER2 Over-Expressing and Basal-Like Breast Cancers and the Association between Lymphocytic Tumor Infiltrate and Prognosis. Modern Pathology. 25A-25A. 2012
- Morphological Characteristics of HER2 Over-Expressing and Basal-Like Breast Cancers and the Association between Lymphocytic Tumor Infiltrate and Prognosis. Laboratory Investigation. 25A-25A. 2012
- Survival analysis of PETCAM: A multicenter randomized controlled trial of PET/CT versus no PET/CT for patients with resectable liver colorectal adenocarcinoma metastases.. Journal of Clinical Oncology. 390-390. 2012
- P2-12-27: Simply Adding Together the Diameters of Tumor Foci in Patients with Multicentric or Multifocal Disease Does Not Add Any Additional Prognostic Information: An Analysis from NCIC CTG MA.12 Randomized Placebo-Controlled Trial of Tamoxifen after Adjuvant Chemotherapy in Pre-Menopausal Women with Early Breast Cancer.. Cancer Research. 2011
- P4-12-05: Impact of the Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer (LISA) Weight Loss Intervention upon Physical Activity.. Cancer Research. 2011
- P5-14-01: Differences in Efficacy by Assessment Method: NCIC CTG Adjuvant Breast Cancer Trials MA.5, MA.12, MA.14, MA.21, MA.27 Meta-Analysis.. Cancer Research. 2011
- An Ontario Clinical Oncology (OCOG) Randomized Trial (PET START) of FDG PET/CT in Stage 3 Non-small Cell Lung Cancer (NSCLC): Impact of PET on Survival. International Journal of Radiation Oncology Biology Physics. S137-S137. 2011
- NCIC-CTG MA. 20: An intergroup trial of regional nodal irradiation in early breast cancer. Journal of Clinical Oncology. 2011
- An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM). Journal of Clinical Oncology. 2011
- An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.. Journal of Clinical Oncology. 2011
- Cost-effectiveness of a survivorship care plan for breast cancer survivors.. Journal of Clinical Oncology. 6082-6082. 2011
- Funding academic oncology clinical trials.. Journal of Clinical Oncology. e16507-e16507. 2011
- Impact of a change of body mass index (BMI) on outcome following adjuvant endocrine therapy, chemotherapy, or trastuzumab for breast cancer.. Journal of Clinical Oncology. 513-513. 2011
- NCIC CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer.. Journal of Clinical Oncology. 2011
- Randomized trial of a lifestyle intervention for women with early-stage breast cancer (BC) receiving adjuvant hormone therapy: Initial results.. Journal of Clinical Oncology. 512-512. 2011
- Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for neck dissection following radiation therapy of head and neck cancer (HNC).. Journal of Clinical Oncology. 2011
- The responsiveness of intrinsic subtypes to adjuvant anthracyclines versus nonanthracyclines in NCIC.CTG MA.5 randomized trial.. Journal of Clinical Oncology. 1032-1032. 2011
- Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism. Blood. 1711-1711. 2010
- Accuracy of computerized tomography (CT) imaging in predicting pathologic stage for patients undergoing surgery for transitional cell carcinoma (TCC) of the bladder.. Journal of Clinical Oncology. e15111-e15111. 2010
- Breast cancer survivors perception of family physician (FP) or specialist as principal provider of routine follow-up care.. Journal of Clinical Oncology. 9090-9090. 2010
- Survival of non-small cell lung cancer (NSCLC) patients in a randomized trial as predicted by the FDG-PET standardized uptake value (SUV).. Journal of Clinical Oncology. 7076-7076. 2010
- OC-03 Randomized phase II trial of an oral factor Xa inhibitor in patients with metastatic cancer on chemotherapy. Thrombosis Research. S161-S162. 2010
- DELTA: A Randomized Trial of Decongestive Lymphatic Therapy for Women with Lymphedema following Treatment for Breast Cancer. International Journal of Radiation Oncology Biology Physics. S53-S53. 2009
- PND46 A SYSTEMATIC REVIEW AND META-ANALYSIS OF INTRAVENOUS IMMUNOGLOBULIN FOR THE TREATMENT OF CIDP. Value in Health. A374-A374. 2009
- 30 PET START: THE FIRST RANDOMIZED CLINICAL TRIAL EVALUATING THE IMPACT OF POSITRON EMISSION TOMOGRAPHY IN STAGE III NON-SMALL CELL LUNG CANCER. Radiotherapy and Oncology. S10-S10. 2009
- Influence of delays to nonemergent colon cancer surgery on operative mortality, disease-specific survival and overall survival.. Canadian Journal of Surgery. E79-E86. 2009
- Apixaban in patients with metastatic cancer: a randomized phase II feasibility study. Journal of Thrombosis and Haemostasis. 792-793. 2009
- Risk factors for recurrent thrombosis and anticoagulant-related bleeding in cancer patients. Journal of Thrombosis and Haemostasis. 107-107. 2009
- The effect of low molecular weight heparin dalteparin in newly diagnosed ovarian cancer: a phase II randomized study. Journal of Thrombosis and Haemostasis. 107-107. 2009
- A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer. Journal of Clinical Oncology. 2009
- Long-term Results of a Randomized Trial of Accelerated Hypofractionated Whole Breast Irradiation Following Breast Conserving Surgery in Women with Node-Negative Breast Cancer. International Journal of Radiation Oncology Biology Physics. S28-S28. 2008
- A prospective study evaluating ¹⁸F-Fluorodeoxyglucose (¹⁸FDG) positron emission tomography (PET) in the assessment of axillary nodal spread in women undergoing sentinel lymph node biopsy (SLNB) for breast cancer. Journal of Clinical Oncology. 533-533. 2008
- A randomized controlled trial (RCT) of ¹⁸F-fluorodeoxyglucose (FDG) positron emission tomography (PET) versus conventional imaging (CI) in staging potentially resectable non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 7502-7502. 2008
- Triple-negative receptor status and prognosis in the NCIC CTG MA. 21 adjuvant breast cancer trial. Journal of Clinical Oncology. 550-550. 2008
- Adjuvant therapy and thrombosis: How to avoid the problem?. Breast. S169-S174. 2007
- Long-term results of a randomized trial of accelerated hypofractionated whole breast irradiation following breast conserving surgery in women with node negative breast cancer. Breast Cancer Research and Treatment. S6-S6. 2007
- A phase III adjuvant trial of sequenced EC plus filgrastim plus epoetin-alpha followed by paclitaxel compared to sequenced AC followed by paclitaxel compared to CEF in women with node-positive or high-risk node-negative breast cancer (NCIC CTG MA.21). Journal of Clinical Oncology. 2007
- A randomized trial of computer and pamphlet-based versions of the Decision Board (DB). Journal of Clinical Oncology. 2007
- S40 Adjuvant therapies and thrombosis: How to avoid the problem?. Breast. S11-S11. 2007
- PO-40 PRODIGE: a randomized placebo-controlled trial of long-term thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma: updated results. Thrombosis Research. S157-S157. 2007
- Prognostic and predictive value of topoisomerase II alpha in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5).. Journal of Clinical Oncology. 11S-11S. 2006
- Topoisomerase II alpha protein overexpression has predictive utility in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5).. Breast Cancer Research and Treatment. S18-S18. 2006
- The effect of doxycycline on bone turnover and tumor markers in breast cancer (BC) patients with skeletal metastases. Journal of Clinical Oncology. 3198-3198. 2005
- Prospective Cohort Study of the Incidence, Risk Factors and Long-Term Sequelae of Symptomatic Catheter-Related Thrombosis in Adults with Cancer.. Blood. 2200-2200. 2004
- Why Cancer Patients Enter Randomized Clinical Trials: Exploring the Factors That Influence Their Decision. Journal of Clinical Oncology. 4312-4318. 2004
- A randomized trial comparing a combination of iridium implant and external beam radiation to external beam radiation alone for patients with locally advanced prostate cancer. International Journal of Radiation Oncology Biology Physics. S448-S448. 2004
- Arm lymphedema in breast cancer patients: Is it always related to treatment. International Journal of Radiation Oncology Biology Physics. S402-S402. 2004
- Post radiotherapy biopsy correlation with PSA failure: Results from a randomized hypofractionated study in localized prostate cancer. International Journal of Radiation Oncology Biology Physics. S171-S171. 2004
- A randomized controlled trial (RCT) of routine follow-up for early stage breast cancer: A comparison of primary care versus specialist care.. Journal of Clinical Oncology. 43S-43S. 2004
- A randomized trial comparing CEF to CME in premenopausal women with node positive breast cancer: update of NCICCTG MA.5.. Breast Cancer Research and Treatment. S33-S33. 2002
- A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE).. Blood. 82A-82A. 2002
- Low molecular weight heparin (LMWH) therapy and survival in advanced cancer.. Blood. 148A-148A. 2002
- Risk of acute leukemia following adjuvant epirubicin-based adjuvant chemotherapy for breast cancer.. Breast Cancer Research and Treatment. 247-247. 2001
- The effects of radiation therapy on quality of life of women with breast carcinoma. Cancer. 2260-2266. 2000
- S35 CEF versus CMF in premenopausal women — Recent update. European Journal of Cancer. S9-S9. 1998
- Formation of heparin-induced thrombocytopenia IgG (HIT-IgG) without thrombocytopenia: Analysis of a clinical trial.. Blood. 2137-2137. 1995
- Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism. Chest. 291S-301S. 1995
- A PROSPECTIVE-STUDY OF HEPARIN-INDUCED THROMBOCYTOPENIA - UNFRACTIONATED HEPARIN COMPARED WITH LOW-MOLECULAR-WEIGHT HEPARIN. Blood. A188-A188. 1994
- ABNORMALITIES IN FIBRINOLYSIS PREDICT FOR RECURRENT DEEP-VEIN THROMBOSIS. Blood. A69-A69. 1994
- EFFICACY OF ANTI-D TO IMPROVE PLATELET TRANSFUSION RESPONSE - A RANDOMIZED TRIAL. Blood. A403-A403. 1993
- A DOUBLE-BLIND RANDOMIZED TRIAL OF MINI-DOSE WARFARIN FOR THE PREVENTION OF THROMBOEMBOLISM (TE) IN PATIENTS WITH STAGE-IV BREAST-CANCER. Thrombosis and Haemostasis. 981-981. 1993
- A RANDOMIZED TRIAL COMPARING THE ACTIVATED THROMBOPLASTIN TIME WITH THE HEPARIN ASSAY TO MONITOR HEPARIN-THERAPY IN PATIENTS WITH ACUTE VENOUS THROMBOEMBOLISM REQUIRING LARGE DAILY DOSES OF HEPARIN. Thrombosis and Haemostasis. 1122-1122. 1993
- COMPARISON OF THE EFFICACY AND COST OF LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) AND STANDARD HEPARIN (SH) FOR THE PREVENTION OF DEEP-VEIN THROMBOSIS (DVT) FOLLOWING TOTAL HIP-REPLACEMENT (THR). Thrombosis and Haemostasis. 650-650. 1993
- HEPARIN-INDUCED THROMBOCYTOPENIA IS MORE COMMON WITH UNFRACTIONATED HEPARIN THAN WITH LOW-MOLECULAR-WEIGHT HEPARIN. Thrombosis and Haemostasis. 911-911. 1993
- OPTIMAL DURATION OF ORAL ANTICOAGULANT-THERAPY - A RANDOMIZED TRIAL COMPARING 4 WEEKS WITH 3 MONTHS OF WARFARIN IN PATIENTS WITH PROXIMAL DEEP-VEIN THROMBOSIS (DVT). Thrombosis and Haemostasis. 982-982. 1993
- VALIDATION OF A NEW CRITERIA FOR THE EVALUATION OF BLEEDING DURING ANTITHROMBOTIC THERAPY. Thrombosis and Haemostasis. 650-650. 1993
- Eligible-non-randomized patients: Their impact on generalizability. Contemporary Clinical Trials. 391-391. 1992
- Impact of a randomized trial on transfusion practice in orthopedic surgery. Contemporary Clinical Trials. 431-431. 1992
- GENERALIZABILITY OF THE RESULTS OF A TRIAL OF RADIATION-THERAPY IN BREAST-CANCER. Clinical Research. A370-A370. 1992
- A DOUBLE-BLIND RANDOMIZED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID VERSUS UNFRACTIONATED HEPARIN IN THE PREVENTION OF DEEP-VEIN THROMBOSIS IN PATIENTS WITH THROMBOTIC STROKE. Thrombosis and Haemostasis. 753-753. 1991
- A BEDSIDE DECISION INSTRUMENT IN EARLY STAGE BREAST-CANCER. Clinical Research. A298-A298. 1991
- ·P-53 Methodological guidelines for randomized clinical trials of surgical procedures. Contemporary Clinical Trials. 299-299. 1990
- Monitoring compliance and contamination in a chemoprevention trial. Contemporary Clinical Trials. 353-354. 1989
- Quality of life in stage 2 breast cancer patients measured by a time trade off method. Contemporary Clinical Trials. 350-350. 1989
- RELATIONSHIP BETWEEN ANTI-FACTOR-XA LEVEL AND CLINICAL OUTCOME IN PATIENTS RECEIVING ENOXAPARINE TO PREVENT DEEP-VEIN THROMBOSIS AFTER HIP-REPLACEMENT. Thrombosis and Haemostasis. 520-520. 1989
- HUMAN TISSUE-TYPE PLASMINOGEN-ACTIVATOR RELEASES FIBRINOPEPTIDE-A AND FIBRINOPEPTIDE-B FROM FIBRINOGEN. Clinical Research. A422-A422. 1988
- A DOUBLE-BLIND RANDOMIZED TRIAL OF ORG-10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN THE PREVENTION OF DEEP-VEIN THROMBOSIS IN PATIENTS WITH THROMBOTIC STROKE. Thrombosis and Haemostasis. 123-123. 1987
- CANCER CHEMOTHERAPY AND THROMBOSIS. Thrombosis and Haemostasis. 114-114. 1987
- DEEP VEIN THROMBOSIS PROPHYLAXIS IN SURGICALLY TREATED FRACTURED HIP PATIENTS. Thrombosis and Haemostasis. 241-241. 1987
- RANDOMIZED CONTROLLED TRIAL OF PK-10169 LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) FOR VENOUS THROMBOSIS PROPHYLAXIS AFTER ELECTIVE HIP-SURGERY. Circulation. 235-235. 1986
- QUALITY-OF-LIFE IN BREAST-CANCER - AN INSTRUMENT FOR CLINICAL-TRIALS. Clinical and Investigative Medicine. A47-A47. 1986
- QUALITY-OF-LIFE IN STAGE-II BREAST-CANCER - AN INSTRUMENT FOR CLINICAL-TRIALS. Breast Cancer Research and Treatment. 102-102. 1986
- CANCER PAIN - HEROIN VERSUS MORPHINE. Clinical Research. A257-A257. 1985
- HEMORRHAGIC COMPLICATIONS OF LONG-TERM ANTICOAGULANT-THERAPY. Thrombosis and Haemostasis. 294-294. 1985
- QUALITY OF LIFE (QL) IN STAGE-2 BREAST-CANCER - USE OF THE TIME TRADE-OFF (TTO) METHOD. Clinical and Investigative Medicine. A87-A87. 1985
- COST-EFFECTIVENESS IN THE DIAGNOSIS AND TREATMENT OF CARCINOMA OF UNKNOWN PRIMARY ORIGIN. Clinical Research. A226-A226. 1984
- TREATMENT OF METASTATIC MELANOMA WITH INTENSIVE 1,3 - BIS(2-CHLOROETHYL) -1- NITROSOUREA (BCNU) AND AUTOLOGOUS MARROW TRANSPLANTATION (AMTX). Proceedings / Annual Meeting of the American Association for Cancer Research [and] Annual Meeting of the American Society of Clinical Oncology. American Association for Cancer Research. Meeting. 532-532. 1981
journal articles
- OPAR: A Randomized Trial of Partial Breast Irradiation in Five Fractions Once Daily for Early Breast Cancer.. Journal of Clinical Oncology. JCO2400600. 2024
- Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical Trial.. JAMA Oncology. 10. 2024
- Feasibility of collecting longitudinal patient-reported outcomes in individuals with relapsed or refractory large B-cell lymphoma who received chimeric antigen receptor T-cell (CART) therapy. BMC Cancer. 24:984. 2024
- Patient-Reported Outcome Measures in Cancer Care. JAMA network open. 7:e2424793-e2424793. 2024
- ASO Visual Abstract: Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis. Annals of Surgical Oncology. 31:4549-4550. 2024
- Breast cancer learning health system: Patient information from a data and analytics platform characterizes care provided. Learning Health Systems. 8:e10409. 2024
- Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis. Annals of Surgical Oncology. 31:4518-4526. 2024
- Oncologists’ Satisfaction with Virtual Care: A Questionnaire. Current Oncology. 31:3269-3277. 2024
- Measurement of adverse cosmesis in breast cancer: A deep learning approach. Expert Systems With Applications. 238:122209-122209. 2024
- LUMINA: Using molecular biomarkers to guide decision making for breast radiotherapy. Radiotherapy and Oncology. 190:110074-110074. 2024
- Omitting Radiotherapy in Luminal A Breast Cancer. New England Journal of Medicine. 389:1727-1728. 2023
- Effective and safe regional node irradiation in early breast cancer. The Lancet. 402:1943-1945. 2023
- Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer. New England Journal of Medicine. 389:612-619. 2023
- Impact of ¹⁸F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced Breast Cancer. Journal of Clinical Oncology. 41:3909-3916. 2023
- Patient reported symptom burden amongst immigrant and Canadian long-term resident women undergoing breast cancer surgery. Breast Cancer Research and Treatment. 199:553-563. 2023
- Developing a Data and Analytics Platform to Enable a Breast Cancer Learning Health System at a Regional Cancer Center. JCO clinical cancer informatics. 7:e2200182. 2023
- FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.. Journal of Clinical Oncology. 41:460-460. 2023
- Use of population-based electronic databases for the identification of patients with synchronous colorectal cancer and liver metastases potentially eligible for a surgical trial. Canadian Journal of Surgery. 66:E52-E58. 2023
- LUSTRE: A Phase III Randomized Trial of Stereotactic Body Radiotherapy (SBRT) vs. Conventionally Hypofractionated Radiotherapy (CRT) for Medically Inoperable Stage I Non-Small Cell Lung Cancer (NSCLC). International Journal of Radiation Oncology Biology Physics. 114:1061-1062. 2022
- Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial. Journal of Experimental and Clinical Cancer Research. 41:255. 2022
- Important questions for the malignant hematologist to consider when designing or evaluating a study with patient‐reported outcome measures (PROMs). European Journal of Haematology. 109:3-9. 2022
- LUMINA: A prospective trial omitting radiotherapy (RT) following breast conserving surgery (BCS) in T₁N₀ luminal A breast cancer (BC).. Journal of Clinical Oncology. 40:LBA501-LBA501. 2022
- Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial. Journal of Surgical Oncology. 125:671-677. 2022
- Simultaneous Resection for Synchronous Colorectal Cancer Liver Metastases: A Feasibility Clinical Trial. HPB. 24:S107-S107. 2022
- Remote, proactive, telephone based management of toxicity in outpatients during adjuvant or neoadjuvant chemotherapy for early stage breast cancer: pragmatic, cluster randomised trial. The BMJ. 375:e066588-e066588. 2021
- Predictive Significance of an Optimized Panel for Basal-like Breast Cancer: Results from the Canadian Cancer Trials Group MA.5 and MA.12 Phase III Clinical Trials. Clinical Cancer Research. 27:6570-6579. 2021
- Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer. JAMA Oncology. 7:1333-1333. 2021
- PO-36 Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D trial. Thrombosis Research. 200:S36-S36. 2021
- Abstract PD12-01: Evaluation of sleep problems and their association with febrile neutropenia, leucopenia and infections in women receiving adjuvant chemotherapy for breast cancer in the Canadian Cancer Trials Group MA.21 trial. Cancer Research. 81:pd12-01-pd12-01. 2021
- Anthracycline-induced cardiotoxicity in patients with early-stage breast cancer: the Canadian Cancer Trials Group (CCTG) MA.21 experience. Breast Cancer Research and Treatment. 184:733-741. 2020
- Virtual Cancer Care During the COVID-19 Pandemic and Beyond: A Call for Evaluation. JMIR Cancer. 6:e24222-e24222. 2020
- Hypofractionated Breast Irradiation: What’s Next?. Journal of Clinical Oncology. 38:3245-3247. 2020
- Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey. Oncologist. 25:e1091-e1097. 2020
- Effect of PET‐CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long‐term results of a randomized controlled trial. Journal of Surgical Oncology. 121:1001-1006. 2020
- Routine Imaging or No Routine Imaging, Is That the Question?. Journal of the National Comprehensive Cancer Network : JNCCN. 18:490-492. 2020
- Treatment of cancer‐associated venous thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomization of the SELECT‐D Trial (SELECT‐D: 12m). Journal of Thrombosis and Haemostasis. 18:905-915. 2020
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology. 38:496-520. 2020
- The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer. npj Breast Cancer. 6:6. 2020
- External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. The Lancet. 394:2165-2172. 2019
- Learning Health System for Breast Cancer: Pilot Project Experience. JCO clinical cancer informatics. 3:1-11. 2019
- Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases. Journal of Surgical Oncology. 120:1420-1426. 2019
- Incidence of delayed venous thromboembolic events in patients undergoing abdominal and pelvic surgery for cancer: a systematic review and meta‐analysis. ANZ Journal of Surgery. 89:1217-1223. 2019
- A meta-analysis exploring the role of PET and PET-CT in the management of potentially resectable colorectal cancer liver metastases. European Journal of Surgical Oncology. 45:1341-1348. 2019
- Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. The Lancet. 393:1440-1452. 2019
- Abstract PD6-04: Lifestyle intervention study (LISA) in early breast cancer (BC): An RCT of the effects of a telephone-based weight loss intervention (with educational materials) vs educational materials alone on disease-free survival (DFS). Cancer Research. 79:pd6-04-pd6-04. 2019
- Venous Thromboembolic Events Following Major Pelvic and Abdominal Surgeries for Cancer: A Prospective Cohort Study. Annals of Surgical Oncology. 25:3214-3221. 2018
- Effect of Positron Emission Tomography Imaging in Women With Locally Advanced Cervical Cancer. JAMA network open. 1:e182081-e182081. 2018
- A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia. Blood Advances. 2:1935-1945. 2018
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). Journal of Clinical Oncology. 36:2017-2023. 2018
- Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases. The long-term results of a randomized controlled trial (PET-CT Imaging prior to liver resection for colorectal adenocarcinoma metastases).. Journal of Clinical Oncology. 36:3527-3527. 2018
- Abstract P2-10-01: Validation that a histone gene signature predicts anthracycline response in early breast cancer. Cancer Research. 78:p2-10-01-p2-10-01. 2018
- Abstract P2-10-04: Targeted sequencing in early breast cancer: Identification of novel candidate mutations predictive of anthracycline benefit. Cancer Research. 78:p2-10-04-p2-10-04. 2018
- Effect of PET-CT on disease recurrence and its management in patients with potentially resectable colorectal cancer liver metastases: The long-term results of a randomized control trial.. Journal of Clinical Oncology. 36:562-562. 2018
- Population-Based Study to Determine the Health System Costs of Using the 21-Gene Assay. Journal of Clinical Oncology. 36:238-243. 2018
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology. 19:27-39. 2018
- Simultaneous resection of colorectal cancer with synchronous liver metastases (RESECT), a pilot study. International Journal of Surgery Protocols. 8:1-6. 2018
- Long-Term Results of a Randomized Trial Comparing Iridium Implant Plus External Beam Radiation Therapy With External Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate. International Journal of Radiation Oncology Biology Physics. 99:90-93. 2017
- Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials. Annals of Oncology. 28:1560-1568. 2017
- Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer. Journal of Clinical Oncology. 35:1884-1890. 2017
- Further considerations on competence by design: when opportunity stops knocking. Canadian Journal of Anaesthesia. 64:430-430. 2017
- Abstract P4-12-09: The immune response in triple negative breast cancer. Cancer Research. 77:p4-12-09-p4-12-09. 2017
- A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group. Lung Cancer. 104:65-69. 2017
- Incidence of venous thromboembolic events following major pelvic and abdominal surgery for cancer.. Journal of Clinical Oncology. 35:478-478. 2017
- Claudin-Low Breast Cancer; Clinical & Pathological Characteristics. PLoS ONE. 12:e0168669-e0168669. 2017
- Young women with breast cancer: Needs and experiences. Cogent Medicine. 4:1278836-1278836. 2017
- The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures. BMC Cancer. 16:555. 2016
- Profit (Prostate Fractionated Irradiation Trial) : résultats d’une étude internationale randomisée comparant deux schémas d’irradiation des cancers de prostate de risque intermédiaire. Progres en Urologie. 26:793-794. 2016
- Prostate Fractionated Irradiation Trial (PROFIT) : résultats d’une étude internationale randomisée comparant deux schémas d’irradiation des cancers de prostate de risque intermédiaire. Cancer/Radiotherapie. 20:710-710. 2016
- A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial. Oncotarget. 7:49099-49106. 2016
- Competency-based medical education: Its time has arrived. Canadian Journal of Anaesthesia. 63:802-806. 2016
- Positron Emission Tomography–Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial. JCO Oncology Practice. 12:e765-e774. 2016
- Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario. Journal of Clinical Oncology. 34:1065-1071. 2016
- A Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation for Patients With Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 17:142-149. 2016
- PET-CT compared to no PET-CT in the management of potentially resectable colorectal cancer liver metastases: The costs implications of a randomized controlled trial.. Journal of Clinical Oncology. 34:296-296. 2016
- Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study. Clinical Lymphoma, Myeloma and Leukemia. 16:18-28.e4. 2016
- Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. BMJ Open. 6:e010569-e010569. 2016
- A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial. Journal of Cancer Survivorship. 9:683-691. 2015
- Regional Nodal Irradiation in Early-Stage Breast Cancer. New England Journal of Medicine. 373:1877-1880. 2015
- A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials. Oncotarget. 6:31693-31701. 2015
- TLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial. British Journal of Cancer. 113:722-728. 2015
- Regional Nodal Irradiation in Early-Stage Breast Cancer. New England Journal of Medicine. 373:307-316. 2015
- Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study. Journal of Bone Oncology. 4:47-53. 2015
- 18F-fluorodeoxyglucose positron-emission tomography-computed tomography to diagnose recurrent cancer. British Journal of Cancer. 112:1737-1743. 2015
- Defining Breast Cancer Intrinsic Subtypes by Quantitative Receptor Expression. Oncologist. 20:474-482. 2015
- Advancing Novel Molecular Imaging Agents from Preclinical Studies to First-in-Humans Phase I Clinical Trials in Academia—A Roadmap for Overcoming Perceived Barriers. Bioconjugate Chemistry. 26:625-632. 2015
- Predictors of Adverse Cosmetic Outcome in the RAPID Trial: An Exploratory Analysis. International Journal of Radiation Oncology Biology Physics. 91:968-976. 2015
- Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer. Breast Cancer Research and Treatment. 150:605-611. 2015
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014. Journal of Clinical Oncology. 33:654-656. 2015
- Preclinical pharmacokinetics, biodistribution, radiation dosimetry and acute toxicity studies required for regulatory approval of a Clinical Trial Application for a Phase I/II clinical trial of 111In-BzDTPA-pertuzumab. Nuclear Medicine and Biology. 42:78-84. 2015
- Kit for the preparation of 111In-labeled pertuzumab injection for imaging response of HER2-positive breast cancer to trastuzumab (Herceptin). Applied Radiation and Isotopes. 95:135-142. 2015
- Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial. Breast Cancer Research and Treatment. 149:439-448. 2015
- Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified times. SpringerPlus. 3:323. 2014
- How Long to Treat Acute Venous Thrombosis in Cancer: Can Treatment Be Personalized?. Journal of Clinical Oncology. 32:3586-3587. 2014
- Treating clots in cancer: moving closer to an answer?. The Lancet Haematology. 1:e6-e7. 2014
- Treatment crossovers in time-to-event non-inferiority randomised trials of radiotherapy in patients with breast cancer. BMJ Open. 4:e006531-e006531. 2014
- PET Screening for Metastatic Colorectal Adenocarcinoma—Reply. Journal of the American Medical Association (JAMA). 312:1256-1256. 2014
- Twenty-Twenty Hindsight: An Adjuvant Breast Cancer Trial Through the Retrospectoscope. Journal of Clinical Oncology. 32:2284-2286. 2014
- Randomized Trial of a Telephone-Based Weight Loss Intervention in Postmenopausal Women With Breast Cancer Receiving Letrozole: The LISA Trial. Journal of Clinical Oncology. 32:2231-2239. 2014
- Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer. Breast Cancer Research and Treatment. 146:447-450. 2014
- Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study. Breast Cancer Research and Treatment. 146:153-162. 2014
- Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases. Journal of the American Medical Association (JAMA). 311:1863-1863. 2014
- Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy. Annals of Oncology. 25:992-998. 2014
- Cost Effectiveness of a Survivorship Care Plan for Breast Cancer Survivors. JCO Oncology Practice. 10:e86-e92. 2014
- Empirical comparison of methods for analyzing multiple time-to-event outcomes in a non-inferiority trial: a breast cancer study. BMC Medical Research Methodology. 13:44. 2013
- Patterns of use and outcomes for radiation therapy in the Quality Initiative in Rectal Cancer (QIRC) trial. Canadian Journal of Surgery. 56:E148-E153. 2013
- Uptake of an innovation in surgery: observations from the cluster-randomized Quality Initiative in Rectal Cancer trial. Canadian Journal of Surgery. 56:415-421. 2013
- Interim Cosmetic and Toxicity Results From RAPID: A Randomized Trial of Accelerated Partial Breast Irradiation Using Three-Dimensional Conformal External Beam Radiation Therapy. Journal of Clinical Oncology. 31:4038-4045. 2013
- Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinical trials. Breast Cancer Research and Treatment. 142:143-151. 2013
- Randomized Trial of Decongestive Lymphatic Therapy for the Treatment of Lymphedema in Women With Breast Cancer. Journal of Clinical Oncology. 31:3758-3763. 2013
- Reply to C.M. Booth et al. Journal of Clinical Oncology. 31:3300-3300. 2013
- Selective Application of a Test Based on Risk: Using Limited Resources Wisely. Journal of Clinical Oncology. 31:2847-2848. 2013
- Data collection in cancer clinical trials: Too much of a good thing?. Clinical Trials. 10:624-632. 2013
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology. 31:2189-2204. 2013
- Randomized phase II placebo-controlled trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone receptor-positive metastatic breast cancer (MBC): OCOG Zamboney study—NCT00811369.. Journal of Clinical Oncology. 31:574-574. 2013
- Central Venous Catheter Care for the Patient With Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology. 31:1357-1370. 2013
- Fluorogenic Probe for Constitutive Cellular Endocytosis. Cell Chemical Biology. 20:614-618. 2013
- Comparative Effectiveness Research in Oncology: An Overview. Journal of Clinical Oncology. 30:4181-4184. 2012
- Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized study. Thrombosis Research. 130:894-900. 2012
- Epilogue: The Peril and the Promise of Comparative Effectiveness Research in Oncology. Journal of Clinical Oncology. 30:4282-4282. 2012
- Accuracy and safety of 99mTc-labeled anti-D-dimer (DI-80B3) Fab’ fragments (ThromboView®) in the diagnosis of deep vein thrombosis: A phase II study. Thrombosis Research. 130:381-389. 2012
- Method to Our Madness or Madness in Our Methods? Pitfalls in Trial Methodology. Journal of Clinical Oncology. 30:2025-2027. 2012
- Positron emission tomography/computed tomography (PET/CT) for the diagnosis of recurrent cancer (PETREC): A multicenter, prospective cohort study.. Journal of Clinical Oncology. 30:6049-6049. 2012
- A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer. Journal of Thrombosis and Haemostasis. 10:807-814. 2012
- Funding Oncology Clinical Trials: Are Cooperative Group Trials Sustainable?. Journal of Clinical Oncology. 30:1456-1461. 2012
- Prospective Study of 2-[¹⁸F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group Study. Journal of Clinical Oncology. 30:1274-1279. 2012
- Reply to M. Jefford et al and C.T. Stricker et al. Journal of Clinical Oncology. 30:1393-1394. 2012
- Responsiveness of Intrinsic Subtypes to Adjuvant Anthracycline Substitution in the NCIC.CTG MA.5 Randomized Trial. Clinical Cancer Research. 18:2402-2412. 2012
- 357 Impact of Survivorship Care Plans (SCP) On Adherence to Guidelines, Health Service Measures, and Patient-reported Outcomes (PRO): Extended Results of a Multicenter Randomized Clinical Trial (RCT) with Breast Cancer Survivors. European Journal of Cancer. 48:S147-S147. 2012
- Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 Trial. Breast Cancer Research and Treatment. 131:541-551. 2012
- Evaluating Survivorship Care Plans: Results of a Randomized, Clinical Trial of Patients With Breast Cancer. Journal of Clinical Oncology. 29:4755-4762. 2011
- P2-12-23: How Should We Assess Tumour Size (T Stage) in Patients with Multicentric/Multifocal Breast Cancer? Results from the NCIC CTG MA.5 Randomized Trial of CEF vs. CMF in Pre-Menopausal Women with Node Positive Breast Cancer.. Cancer Research. 71:p2-12-23-p2-12-23. 2011
- Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios. ACP journal club. 155:653-653. 2011
- Competing events in patients with malignant disease who are at risk for recurrent venous thromboembolism. Contemporary Clinical Trials. 32:829-833. 2011
- Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography Trial. Journal of Thoracic Oncology. 6:1367-1372. 2011
- Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials. The Lancet. 378:771-784. 2011
- Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial. Breast Cancer Research and Treatment. 128:401-409. 2011
- NCIC-CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer.. Journal of Clinical Oncology. 29:LBA1003-LBA1003. 2011
- An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM).. Journal of Clinical Oncology. 29:3520-3520. 2011
- An Ontario Clinical Oncology Group (OCOG) randomized trial (PET START) of FDG PET/CT in patients with stage III non-small cell lung cancer (NSCLC): Predictors of overall survival.. Journal of Clinical Oncology. 29:7018-7018. 2011
- NCIC CTG MA.20: An intergroup trial of regional nodal irradiation in early breast cancer.. Journal of Clinical Oncology. 29:LBA1003-LBA1003. 2011
- Results of a multicenter randomized trial to evaluate a survivorship care plan for breast cancer survivors.. Journal of Clinical Oncology. 29:9005-9005. 2011
- Results of an Ontario Clinical Oncology Group (OCOG) prospective cohort study on the use of FDG PET/CT to predict the need for neck dissection following radiation therapy of head and neck cancer (HNC).. Journal of Clinical Oncology. 29:5504-5504. 2011
- Coverage with evidence development: The Ontario experience. International Journal of Technology Assessment in Health Care. 27:159-168. 2011
- Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138 769 individuals. Journal of Hypertension. 29:623-635. 2011
- Expectant management versus immediate treatment for low‐grade cervical intraepithelial neoplasia. Cancer. 117:1438-1445. 2011
- The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal‐based and cell‐based models. Journal of Thrombosis and Haemostasis. 9:767-775. 2011
- Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism. Blood. 116:4209-4209. 2010
- Assessing the Volume-Outcome Hypothesis and Region-Level Quality Improvement Interventions: Pancreas Cancer Surgery in Two Canadian Provinces. Annals of Surgical Oncology. 17:2537-2544. 2010
- Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast. Journal of the National Cancer Institute. Monographs. 2010:162-177. 2010
- The cluster-randomized Quality Initiative in Rectal Cancer trial: evaluating a quality-improvement strategy in surgery. CANADIAN MEDICAL ASSOCIATION JOURNAL. 182:1301-1306. 2010
- PRODIGE: a randomized placebo‐controlled trial of dalteparin low‐molecular‐weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma. Journal of Thrombosis and Haemostasis. 8:1959-1965. 2010
- Medical student impressions of anesthesiology and anesthesiologists. Canadian Journal of Anaesthesia. 57:792-793. 2010
- Reply to C.D. Atkins. Journal of Clinical Oncology. 28:e264-e264. 2010
- Hypofractionated Radiotherapy for Breast Cancer. New England Journal of Medicine. 362:1843-1844. 2010
- Conventional and Complementary Therapies: A Tale of Two Research Standards?. Journal of Clinical Oncology. 28:1979-1981. 2010
- Thromboprophylaxis during chemotherapy: NO. Thrombosis Research. 125:S16-S16. 2010
- Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer. New England Journal of Medicine. 362:513-520. 2010
- Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer. Journal of Clinical Oncology. 28:77-82. 2010
- Impact of Chemotherapy on Thrombin Generation and on the Protein C Pathway in Breast Cancer Patients. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 37:88-97. 2010
- Response: Re: Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy. Journal of the National Cancer Institute. 101:1736-1737. 2009
- Evidence-Based Approach to the Introduction of Positron Emission Tomography in Ontario, Canada. Journal of Clinical Oncology. 27:5607-5613. 2009
- PET–CT imaging in non-small-cell lung cancer. Nature Reviews Clinical Oncology. 6:619-620. 2009
- New Antithrombotic Drugs: Potential for Use in Oncology. Journal of Clinical Oncology. 27:4912-4918. 2009
- Prevention of Thrombosis in Ambulatory Patients With Cancer. Journal of Clinical Oncology. 27:4885-4888. 2009
- Positron Emission Tomography Plus Computed Tomography for Staging Early Lung Cancer. ACP journal club. 151:I-I. 2009
- Positron Emission Tomography in Staging Early Lung Cancer. ACP journal club. 151:221-221. 2009
- Abstracts of presentations to the Annual Meetings of the Canadian Association of General Surgeons Canadian Association of Thoracic Surgeons Canadian Hepato-Pancreato-Biliary Society Canadian Society of Surgical Oncology Canadian Society of Colon and Rectal Surgeons: Victoria, BC Sept. 10-13, 2009.. Canadian Journal of Surgery. 52:S1-S48. 2009
- A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer. Journal of Clinical Oncology. 27:e20514-e20514. 2009
- Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: A phase II randomized study. Journal of Clinical Oncology. 27:e16529-e16529. 2009
- Impact of positron emission tomography (PET) in stage III non-small cell lung cancer (NSCLC): A prospective randomized trial (PET START). Journal of Clinical Oncology. 27:7548-7548. 2009
- PET-CT compared to invasive mediastinal staging in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 27:7575-7575. 2009
- Predictors of recurrent thrombosis and anticoagulant-related bleeding in patients with cancer. Journal of Clinical Oncology. 27:9565-9565. 2009
- Topoisomerase II Alpha and Responsiveness of Breast Cancer to Adjuvant Chemotherapy. Journal of the National Cancer Institute. 101:644-650. 2009
- P-selectin ready for prime time?. Blood. 113:1860-1860. 2009
- Randomized, Double-Blind, Placebo-Controlled Trial of Epoetin Alfa in Men With Castration-Resistant Prostate Cancer and Anemia. Journal of Clinical Oncology. 27:644-646. 2009
- The Quality Initiative in Rectal Cancer (QIRC) trial: study protocol of a cluster randomized controlled trial in surgery. BMC Surgery. 8:4. 2008
- Registries That Show Efficacy: Good, but Not Good Enough. Journal of Clinical Oncology. 26:5316-5319. 2008
- Surgical outcomes in women with ovarian cancer.. Canadian Journal of Surgery. 51:346-354. 2008
- Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial. Breast Cancer Research and Treatment. 110:337-342. 2008
- Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment. Chest. 133:257S-298S. 2008
- Preface to Second Review Issue on Breast Cancer. Journal of Clinical Oncology. 26:695-695. 2008
- Randomized Trial of High-Dose Chemotherapy With Autologous Peripheral-Blood Stem-Cell Support Compared With Standard-Dose Chemotherapy in Women With Metastatic Breast Cancer: NCIC MA.16. Journal of Clinical Oncology. 26:37-43. 2008
- In Reply. Journal of Clinical Oncology. 25:5667-5667. 2007
- American Society of Clinical Oncology Guideline: Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer. Journal of Clinical Oncology. 25:5490-5505. 2007
- American Society of Clinical Oncology 2007 Clinical Practice Guideline Recommendations for Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer. JCO Oncology Practice. 3:326-329. 2007
- A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes. Annals of Oncology. 18:1646-1651. 2007
- EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT). Journal of Thrombosis and Haemostasis. 5:p-s-606-p-s-606. 2007
- A phase III adjuvant trial of sequenced EC + filgrastim + epoetin-alpha followed by paclitaxel compared to sequenced AC followed by paclitaxel compared to CEF in women with node-positive or high-risk node-negative breast cancer (NCIC CTG MA.21). Journal of Clinical Oncology. 25:550-550. 2007
- A randomized trial of computer and pamphlet-based versions of the Decision Board (DB). Journal of Clinical Oncology. 25:6508-6508. 2007
- PRODIGE: A phase III randomized placebo-controlled trial of thromboprophylaxis using dalteparin low molecular weight heparin (LMWH) in patients with newly diagnosed malignant glioma. Journal of Clinical Oncology. 25:2011-2011. 2007
- Screening cancer patients for clinical trial eligibility: A randomized study. Journal of Clinical Oncology. 25:6529-6529. 2007
- Randomized, Double-Blind, Placebo-Controlled Trial of Erythropoietin in Non–Small-Cell Lung Cancer With Disease-Related Anemia. Journal of Clinical Oncology. 25:1027-1032. 2007
- Economic Evaluation in the Journal of Clinical Oncology: Past, Present, and Future. Journal of Clinical Oncology. 25:614-616. 2007
- Adjuvant therapy and thrombosis: How to avoid the problem?. Breast. 16:169-174. 2007
- Colposcopists' agreement on cervical biopsy site.. Clinical and Experimental Obstetrics and Gynecology. 34:88-90. 2007
- Adjuvant Chemotherapy for Breast Cancer — 30 Years Later. New England Journal of Medicine. 355:1920-1922. 2006
- Outcomes for systemic therapy in women with ovarian cancer. Gynecologic Oncology. 103:554-558. 2006
- Anthracyclines in Early Breast Cancer. New England Journal of Medicine. 355:845-846. 2006
- In Reply. Journal of Clinical Oncology. 24:3711-3712. 2006
- Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario.. Canadian Journal of Surgery. 49:251-258. 2006
- Colposcopists' Agreement on Cervical Biopsy Site. Journal of Lower Genital Tract Disease. 10:172-172. 2006
- A randomized controlled trial (RCT) of long-term follow-up for early stage breast cancer comparing family physician to specialist care: A report of secondary outcomes. Journal of Clinical Oncology. 24:6003-6003. 2006
- Effects of adjuvant chemotherapy on the protein C anticoagulant pathway in patients with early stage breast cancer. Journal of Clinical Oncology. 24:8563-8563. 2006
- Left ventricular function following adjuvant chemotherapy for breast cancer: The NCIC CTG MA5 experience. Journal of Clinical Oncology. 24:522-522. 2006
- Prognostic and predictive value of topoisomerase II alpha in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5). Journal of Clinical Oncology. 24:533-533. 2006
- HER2and Responsiveness of Breast Cancer to Adjuvant Chemotherapy. New England Journal of Medicine. 354:2103-2111. 2006
- Incidence, Risk Factors, and Outcomes of Catheter-Related Thrombosis in Adult Patients With Cancer. Journal of Clinical Oncology. 24:1404-1408. 2006
- Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care. Journal of Clinical Oncology. 24:848-855. 2006
- The Importance of Reporting Patient Recruitment Details in Phase III Trials. Journal of Clinical Oncology. 24:843-845. 2006
- Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question. Journal of Thrombosis and Haemostasis. 4:16-18. 2006
- Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. The Lancet. 366:2087-2106. 2005
- Trastuzumab Cardiac Side Effects: Only Time Will Tell. Journal of Clinical Oncology. 23:7775-7776. 2005
- Enoxaparin in the Treatment of Deep Vein Thrombosis With or Without Pulmonary Embolism. Chest. 128:2203-2210. 2005
- In Reply:. Journal of Clinical Oncology. 23:7250-7250. 2005
- In Reply:. Journal of Clinical Oncology. 23:7244-7244. 2005
- In Reply:. Journal of Clinical Oncology. 23:6267-6267. 2005
- Incidence and Prognostic Impact of Amenorrhea During Adjuvant Therapy in High-Risk Premenopausal Breast Cancer: Analysis of a National Cancer Institute of Canada Clinical Trials Group Study—NCIC CTG MA.5. Journal of Clinical Oncology. 23:6002-6008. 2005
- Randomized Trial Comparing Two Fractionation Schedules for Patients With Localized Prostate Cancer. Journal of Clinical Oncology. 23:6132-6138. 2005
- Treatment of Venous Thromboembolism in Cancer Patients. Cancer Control. 12:17-21. 2005
- Randomized Trial Comparing Cyclophosphamide, Epirubicin, and Fluorouracil With Cyclophosphamide, Methotrexate, and Fluorouracil in Premenopausal Women With Node-Positive Breast Cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5. Journal of Clinical Oncology. 23:5166-5170. 2005
- The importance of temporal effects in evaluating the prognostic impact of joint ERPR expression in premenopausal women with node-positive breast cancer. Breast Cancer Research and Treatment. 92:115-123. 2005
- Catheter-Associated Thrombosis: Thromboprophylaxis or Not?. Journal of Clinical Oncology. 23:4006-4008. 2005
- In Reply:. Journal of Clinical Oncology. 23:3633-3634. 2005
- Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CANADIAN MEDICAL ASSOCIATION JOURNAL. 172:1319-1320. 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. The Lancet. 365:1687-1717. 2005
- Grow your own: strategies to develop anesthesia researchers. Canadian Journal of Anaesthesia. 52:437-437. 2005
- Randomized Comparison of Low Molecular Weight Heparin and Coumarin Derivatives on the Survival of Patients With Cancer and Venous Thromboembolism. Journal of Clinical Oncology. 23:2123-2129. 2005
- Using administrative databases to measure waiting times for patients undergoing major cancer surgery in Ontario, 1993-2000.. Canadian Journal of Surgery. 48:137-142. 2005
- Preface to Special Edition on Breast Cancer. Journal of Clinical Oncology. 23:1595-1595. 2005
- Randomized Trial Comparing Iridium Implant Plus External-Beam Radiation Therapy With External-Beam Radiation Therapy Alone in Node-Negative Locally Advanced Cancer of the Prostate. Journal of Clinical Oncology. 23:1192-1199. 2005
- Home-treatment of deep vein thrombosis in patients with cancer.. Hematology Journal. 90:150. 2005
- More Evidence That Locoregional Radiation Therapy Improves Survival: What Should We Do?. Journal of the National Cancer Institute. 97:82-84. 2005
- Outcomes of postmastectomy radiotherapy. CANADIAN MEDICAL ASSOCIATION JOURNAL. 172:18-18. 2005
- Outcomes of postmastectomy radiotherapy. CANADIAN MEDICAL ASSOCIATION JOURNAL. 172:19-19. 2005
- Anti-Xa effect of a low molecular weight heparin (dalteparin) does not accumulate in extended duration therapy for venous thromboembolism in cancer patients. Thrombosis and Haemostasis. 93:1185-1188. 2005
- Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question. Journal of Clinical Oncology. 23:1-4. 2005
- A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer. Women's Oncology Review. 4:307-308. 2004
- Pilot Study of the Quality Initiative in Rectal Cancer Strategy. Diseases of the Colon and Rectum. 47:1594-1598. 2004
- A Prospective Evaluation of Positron Emission Tomography Scanning, Sentinel Lymph Node Biopsy, and Standard Axillary Dissection for Axillary Staging in Patients with Early Stage Breast Cancer. Annals of Surgical Oncology. 11:846-853. 2004
- A randomized trial comparing a combination of iridium implant and external beam radiation to external beam radiation alone for patients with locally advanced prostate cancer. International Journal of Radiation Oncology Biology Physics. 60:S448-S448. 2004
- Arm lymphedema in breast cancer patients: Is it always related to treatment. International Journal of Radiation Oncology Biology Physics. 60:S402-S402. 2004
- Helping patients decide: Use of a decision aid for breast cancer surgery. Journal of Clinical Outcomes Management. 11:546-550. 2004
- Hemorrhagic Complications of Anticoagulant Treatment. Chest. 126:287S-310S. 2004
- Treatment of locally advanced breast cancer. CANADIAN MEDICAL ASSOCIATION JOURNAL. 171:221-222. 2004
- Treatment of locally advanced breast cancer. CANADIAN MEDICAL ASSOCIATION JOURNAL. 171:219-219. 2004
- Thrombosis and cancer: implications beyond Trousseau. Journal of Thrombosis and Haemostasis. 2:1261-1262. 2004
- Effect of a Decision Aid on Knowledge and Treatment Decision Making for Breast Cancer Surgery. Journal of the American Medical Association (JAMA). 292:435-435. 2004
- A randomized controlled trial (RCT) of routine follow-up for early stage breast cancer: A comparison of primary care versus specialist care. Journal of Clinical Oncology. 22:665-665. 2004
- A randomized controlled trial (RCT) of routine follow-up for early stage breast cancer: A comparison of primary care versus specialist care. Journal of Clinical Oncology. 22:665-665. 2004
- Patterns of trastuzumab (T) use in three Canadian provinces. Journal of Clinical Oncology. 22:633-633. 2004
- Patterns of trastuzumab (T) use in three Canadian provinces. Journal of Clinical Oncology. 22:633-633. 2004
- Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS). Journal of Clinical Oncology. 22:1944-1948. 2004
- Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CANADIAN MEDICAL ASSOCIATION JOURNAL. 170:1263-1273. 2004
- Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer. CANADIAN MEDICAL ASSOCIATION JOURNAL. 170:983-994. 2004
- Compliance with recommended prophylaxis for venous thromboembolism: improving the use and rate of uptake of clinical practice guidelines. Journal of Thrombosis and Haemostasis. 2:221-227. 2004
- Economics of Preoperative Radiotherapy With Total Mesorectal Excision: What Can We Learn From the Dutch Experience?. Journal of Clinical Oncology. 22:217-219. 2004
- The Initial Health Assessment: an intervention to identify the supportive care needs of cancer patients. Supportive Care in Cancer. 12:19-24. 2004
- Researching the Cost of Research. Journal of Clinical Oncology. 21:4081-4082. 2003
- Dalteparin Compared with an Oral Anticoagulant for Thromboprophylaxis in Patients with Cancer. New England Journal of Medicine. 349:1385-1387. 2003
- Dalteparin compared with an oral anticoagulant for thromboprophylaxis in patients with cancer - The authors reply. New England Journal of Medicine. 349:1386-1386. 2003
- A randomized trial comparing two fractionation schedules for patients with localized prostate cancer. International Journal of Radiation Oncology Biology Physics. 57:S126-S126. 2003
- Risk of Acute Leukemia Following Epirubicin-Based Adjuvant Chemotherapy: A Report From the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology. 21:3066-3071. 2003
- Venous Thrombosis in Cancer Patients: Insights from the FRONTLINE Survey. Oncologist. 8:381-388. 2003
- Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer. New England Journal of Medicine. 349:146-153. 2003
- From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer. Journal of Thrombosis and Haemostasis. 1:1456-1463. 2003
- Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with non-metastatic malignancy and venous thromboembolism (VTE). Journal of Thrombosis and Haemostasis. 1:OC004-OC004. 2003
- Venous Thromboembolism and Cancer: Risks and Outcomes. Circulation. 107:I17-I21. 2003
- Can we optimise treatment of thrombosis?. Cancer Treatment Reviews. 29:19-22. 2003
- Introduction. Cancer Treatment Reviews. 29:1-1. 2003
- Re: Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer. Journal of the National Cancer Institute. 95:759-759. 2003
- Re: Is Less More? Lessons in Radiation Schedules in Breast Cancer. Journal of the National Cancer Institute. 95:685-686. 2003
- CORRESPONDENCE. Journal of Clinical Oncology. 21:1895-1895. 2003
- Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer. Journal of the National Cancer Institute. 95:581-587. 2003
- Clinical practice guidelines for the care and treatment of breast cancer: breast radiotherapy after breast-conserving surgery (summary of the 2003 update).. CANADIAN MEDICAL ASSOCIATION JOURNAL. 168:437-439. 2003
- neu/erbB-2 Overexpression and Response to Hormonal Therapy in Premenopausal Women in the Adjuvant Breast Cancer Setting: Will It Play in Peoria? Part II. Journal of Clinical Oncology. 21:399-400. 2003
- Low-Molecular-Weight Heparin or Oral Anticoagulation for Secondary Prevention of Deep Vein Thrombosis in Cancer Patients. Seminars in Vascular Medicine. 29:009-012. 2003
- Risk Assessment and Primary VTE Prevention in the Cancer Patient. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 33:36-41. 2003
- Thrombotic Disorders: Diagnosis and Treatment. Hematology. American Society of Hematology. Education Program. 2003:520-539. 2003
- Venous Thromboembolism and Its Treatment in High-Risk Groups. Seminars in Vascular Medicine. 29:001-002. 2003
- Outcomes in Surgery for Ovarian Cancer. Gynecologic Oncology. 87:260-267. 2002
- Caution with breast-conserving surgery.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 167:1099. 2002
- Do Quality-of-Life Randomized Clinical Trials Support Clinicians in Their Decision-Making?. Journal of Clinical Oncology. 20:4126-4127. 2002
- Do quality-of-life randomized clinical trials support clinicians in their decision-making? Reply. Journal of Clinical Oncology. 20:4127-4127. 2002
- Randomized Trial of Breast Irradiation Schedules After Lumpectomy for Women With Lymph Node-Negative Breast Cancer. Journal of the National Cancer Institute. 94:1143-1150. 2002
- Clinical practice guidelines for the care and treatment of breast cancer: mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer (summary of the 2002 update).. CANADIAN MEDICAL ASSOCIATION JOURNAL. 167:154-155. 2002
- Introduction: building on a heritage in thrombosis – perspectives in cancer care. Cancer Treatment Reviews. 28:131-131. 2002
- Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer. Cancer Treatment Reviews. 28:145-149. 2002
- What is the role for antithrombotics in cancer care?. Cancer Treatment Reviews. 28:157-159. 2002
- A randomized controlled trial comparing the frequency of acute reactions to plasma‐removed platelets and prestorage WBC‐reduced platelets. Transfusion. 42:556-566. 2002
- Beyond the Development of Quality-of-Life Instruments: Where Do We Go From Here?. Journal of Clinical Oncology. 20:2215-2216. 2002
- Clinical practice guidelines for the care and treatment of breast cancer: 14. The role of hormone replacement therapy in women with a previous diagnosis of breast cancer.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 166:1017-1022. 2002
- Breast Cancer Consensus Meetings: Vive la Difference?. Journal of Clinical Oncology. 20:1719-1920. 2002
- Radiotherapy for Breast Cancer. New England Journal of Medicine. 346:862-864. 2002
- Body size, received dose-intensity and myelotoxicity of adjuvant chemotherapy in relation to outcome of premenopausal women with N1 breast cancer: Results from a National Cancer Institute of Canada randomized controlled trial. Breast Cancer Research and Treatment. 69:261. 2001
- Decision-Making Process--Communicating Risk/Benefits: Is There an Ideal Technique?. Journal of the National Cancer Institute. Monographs. 2001:143-145. 2001
- Give us clear, not convoluted, clinical practice guidelines.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:1468. 2001
- Clinical practice guidelines for the care and treatment of breast cancer: the management of chronic pain in patients with breast cancer (summary of the 2001 update).. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:1218-1219. 2001
- Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update).. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:912-913. 2001
- The Role of Aggressive Surgery in Advanced Epithelial Ovarian Cancer. Journal of Obstetrics and Gynaecology Canada. 23:931-935. 2001
- Chemotherapy for older women with node-positive breast cancer.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:525-527. 2001
- A snapshot of waiting times for cancer surgery provided by surgeons affiliated with regional cancer centres in Ontario.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:421-425. 2001
- Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:166-173. 2001
- Raloxifene: handle with care.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:151-153. 2001
- Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 164:1681-1690. 2001
- Baseline staging tests in primary breast cancer: a practice guideline.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 164:1439-1444. 2001
- A randomized trial of high-dose chemotherapy (HDCT) with autologous peripheral blood stem cell support (asct) compared to standard chemo therapy (ct) in women with metastatic breast cancer: a National Cancer Institute of Canada (NCIC) clinical trials group study. European Journal of Cancer. 37:S285-S285. 2001
- Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 164:644-646. 2001
- Management of Venous Thrombosis in Cancer. Recent Developments in Diagnosis, Prevention, and Treatment. Tumori. 87:24-26. 2001
- Erratum: Clinical practice guidlines for the care and treatment of breast cancer: Adjuvant systemic therapy for node-negative breast cancer (Canadian Medical Association Journal (January 23, 2001) 164:2 (213)). CANADIAN MEDICAL ASSOCIATION JOURNAL. 164:465. 2001
- Anthracycline Adjuvant Chemotherapy: How Much Is Enough?. Journal of Clinical Oncology. 19:599-601. 2001
- Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 164:191-199. 2001
- Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update).. CANADIAN MEDICAL ASSOCIATION JOURNAL. 164:213. 2001
- Epidemiology of Thrombosis in Cancer. Acta Haematologica. 106:6-12. 2001
- Hemorrhagic Complications of Anticoagulant Treatment. Chest. 119:108S-121S. 2001
- Management of thromboembolic disease in cancer patients.. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 31 Suppl 1:68-69. 2001
- Raloxifene: Handle with care [3]. CANADIAN MEDICAL ASSOCIATION JOURNAL. 165:149-150. 2001
- Treatment of Venous Thrombosis in the Cancer Patient. Acta Haematologica. 106:81-87. 2001
- Comparison of post transfusion platelet response following random donor and apheresis platelets. Blood. 96. 2000
- Epirubicin in Breast Cancer: Present and Future. Clinical Breast Cancer. 1:S62-S67. 2000
- The McCarthy/Swain article reviewed. Oncology. 14:1284-+. 2000
- Better Treatments That Cost More: The Dilemma. Gynecologic Oncology. 78:1-2. 2000
- Does Locoregional Radiation Therapy Improve Survival in Breast Cancer? A Meta-Analysis. Journal of Clinical Oncology. 18:1220-1229. 2000
- A Cross-Cultural Consumer-Based Decision Aid for Screening Mammography. Preventive Medicine. 30:200-208. 2000
- Lessons learned from the Decision Board: a unique and evolving decision aid. Health Expectations. 3:69-76. 2000
- Management of venous thromboembolism in cancer patients.. Oncology. 14:409-421. 2000
- The use of trastuzumab (Herceptin®) for the treatment of metastatic breast cancer and methods of assessing HER2/neu status - An evidence summary. Current Oncology. 7:242-251. 2000
- Use of capecitabine in stage IV breast cancer: An evidence summary. Current Oncology. 7:84-90. 2000
- Use of vinorelbine in stage IV breast cancer: An evidence summary. Current Oncology. 7:24-28. 2000
- Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis. JAMA Internal Medicine. 159:2298-2304. 1999
- Recurrent Venous Thrombosis and Heparin Therapy. JAMA Internal Medicine. 159:2029-2029. 1999
- Clinical Utility of a Rapid Whole-Bloodd-Dimer Assay in Patients with Cancer Who Present with Suspected Acute Deep Venous Thrombosis. ACP journal club. 131:417-417. 1999
- Mastectomy or Lumpectomy? Helping Women Make Informed Choices. Journal of Clinical Oncology. 17:1727-1727. 1999
- The Thrombophilic State Induced by Therapeutic Agents in the Cancer Patient. Seminars in Vascular Medicine. 25:137-145. 1999
- Treatment of Venous Thromboembolism in Cancer Patients. Seminars in Vascular Medicine. 25:245-249. 1999
- A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion. 39:231-238. 1999
- 2190 Longer term follow-up of a prospective, randomized placebo controlled trial of concomitant chemotherapy and radiation vs radiation alone for advanced stage head and neck cancers. International Journal of Radiation Oncology Biology Physics. 45:375-376. 1999
- Conclusion. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 29:128-129. 1999
- Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread. Thrombosis and Haemostasis. 82:947-952. 1999
- The role of adjuvant systemic therapy in node-negative breast cancer. Current Oncology. 6:78-89. 1999
- Thromboembolism: New Achievements and Challenges - Proceedings of the 6th International Symposium on Thromboembolic Diseases - Lisbon, June 4-5, 1999 - Preface. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 29. 1999
- Use of biphosphonates in patients with bone metastases from breast cancer. Current Oncology. 6:144-154. 1999
- Adjuvant chemotherapy with CEF versus CMF for node-positive breast cancer.. Journal of Clinical Oncology. 16:3916-3917. 1998
- Hemorrhagic Complications of Anticoagulant Treatment. Chest. 114:511S-523S. 1998
- Evaluation of a patient file folder to improve the dissemination of written information materials for cancer patients. Cancer. 83:1620-1625. 1998
- Polychemotherapy for early breast cancer: an overview of the randomised trials. The Lancet. 352:930-942. 1998
- Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. Journal of Clinical Oncology. 16:2651-2658. 1998
- Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.. Journal of Clinical Oncology. 16:2651-2658. 1998
- Tamoxifen for early breast cancer: an overview of the randomised trials. The Lancet. 351:1451-1467. 1998
- Progress of clinical oncology guidelines development using the Practice Guidelines Development Cycle: the role of practitioner feedback.. Journal of Clinical Oncology. 16:1226-1231. 1998
- 1. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. CANADIAN MEDICAL ASSOCIATION JOURNAL. 158:S3-S8. 1998
- A randomized trial comparing combination of iridium implant and external beam radiation vs. external beam radiation alone in node negative locally advanced cancer of the prostate: Preliminary report. International Journal of Radiation Oncology Biology Physics. 42:302-302. 1998
- Adjuvant systemic therapy for women with node-negative breast cancer. CANADIAN MEDICAL ASSOCIATION JOURNAL. 158:S43-S51. 1998
- Adjuvant systemic therapy for women with node-positive breast cancer. CANADIAN MEDICAL ASSOCIATION JOURNAL. 158:S52-S64. 1998
- Axillary dissection. CANADIAN MEDICAL ASSOCIATION JOURNAL. 158:S22-S26. 1998
- Breast radiotherapy after breast-conserving surgery. CANADIAN MEDICAL ASSOCIATION JOURNAL. 158:S35-S42. 1998
- Clinical practice guidelines for the care and treatment of breast cancer - A Canadian consensus document - Introduction. CANADIAN MEDICAL ASSOCIATION JOURNAL. 158:S1-S2. 1998
- Follow-up after treatment for breast cancer. CANADIAN MEDICAL ASSOCIATION JOURNAL. 158:S65-S70. 1998
- Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer. CANADIAN MEDICAL ASSOCIATION JOURNAL. 158:S15-S21. 1998
- The Effect of Very-low-dose Warfarin on Markers of Hypercoagulation in Metastatic Breast Cancer: Results from a Randomized Trial. Thrombosis and Haemostasis. 79:23-27. 1998
- The Occurrence of Subsequent Malignancy in Patients Presenting with Deep Vein Thrombosis: Results from a Historical Cohort Study. Thrombosis and Haemostasis. 79:19-22. 1998
- Treatment of Venous Thromboembolism in Cancer Patients. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 28:66-70. 1998
- Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 28:43-49. 1998
- Erratum: Surgical management of early stage invasive breast cancer (stage I and II) (Cancer Prevention and Control (1997) 1 (10-17)). Cancer Prevention and Control. 1:132. 1997
- PP15. Methods for conducting economic analysis of the long-term management of breast cancer: Description of two current Canadian studies. European Journal of Cancer. 33:S19-S20. 1997
- The supportive care needs of newly diagnosed cancer patients attending a regional cancer center. Cancer. 80:1518-1524. 1997
- Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial Breast Disease Site Group.. Cancer Prevention and Control. 1:228-240. 1997
- Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. Blood Coagulation and Fibrinolysis. 8:216-222. 1997
- Fibrinogenolysis and thrombin generation after reduced dose bolus or conventional rt-PA for pulmonary embolism. The Coagulation Project Investigators of the Bolus Alteplase Pulmonary Embolism Group.. Blood Coagulation and Fibrinolysis. 8:216-222. 1997
- Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.. Journal of Clinical Oncology. 15:2302-2311. 1997
- Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Cancer/Radiotherapie. 1:266-267. 1997
- Radiation therapy following breast conservation surgery: Can it ever be avoided?. Annals of Oncology. 8:217-218. 1997
- Economic and policy implications of adopting paclitaxel as first-line therapy for advanced ovarian cancer: an Ontario perspective.. Journal of Clinical Oncology. 15:632-639. 1997
- A Randomized Trial of Paracentesis plus Intraperitoneal Tumor Necrosis Factor-α versus Paracentesis Alone in Patients with Symptomatic Ascites from Recurrent Ovarian Carcinoma. Gynecologic Oncology. 64:80-87. 1997
- Prevention of Thrombotic Disorders in Cancer Patients Undergoing Chemotherapy. Thrombosis and Haemostasis. 78:133-136. 1997
- Surgical management of early stage invasive breast cancer (stage I and II). Provincial Breast Disease Site Group.. Cancer Prevention and Control. 1:10-17. 1997
- The clinical practice guideline: an evolving health care technology.. Cancer Prevention and Control. 1:7-8. 1997
- Treatment of Thrombotic Disorders in Cancer Patients. Pathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis research. 27:38-43. 1997
- Randomized Clinical Trial of Breast Irradiation Following Lumpectomy and Axillary Dissection for Node-Negative Breast Cancer: an Update. Journal of the National Cancer Institute. 88:1659-1664. 1996
- Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.. Journal of the National Cancer Institute. 88:1659-1664. 1996
- Ardeparin plus graduated compression stockings prevented DVT after knee surgery. Evidence-Based Medicine. 1:213. 1996
- Ovarian ablation in early breast cancer: overview of the randomised trials. The Lancet. 348:1189-1196. 1996
- The Ontario Cancer Treatment Practice Guidelines Initiative.. Oncology. 10:19-22. 1996
- A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer. 78:1470-1476. 1996
- Patients’ Preferences for Therapy in Advanced Epithelial Ovarian Cancer: Development, Testing, and Application of a Bedside Decision Instrument. Gynecologic Oncology. 62:329-335. 1996
- Unfractionated versus Low-Molecular-Weight Heparin for Deep Venous Thrombosis. New England Journal of Medicine. 335:670-672. 1996
- Gene Therapy: Socioeconomic and Ethical Issues A Roundtable Discussion. Human gene therapy. Clinical development. 7:1139-1144. 1996
- A randomised trial of two information packages distributed to new cancer patients before their initial appointment at a regional cancer centre. British Journal of Cancer. 73:1588-1593. 1996
- Update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based clinical practice guidelines. American Society of Clinical Oncology.. Journal of Clinical Oncology. 14:1957-1960. 1996
- Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery. JAMA Internal Medicine. 156:851-856. 1996
- A Comparison of Low-Molecular-Weight Heparin Administered Primarily at Home with Unfractionated Heparin Administered in the Hospital for Proximal Deep-Vein Thrombosis. New England Journal of Medicine. 334:677-681. 1996
- Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.. Journal of Clinical Oncology. 14:671-679. 1996
- Plasma Inorganic Fluoride Concentrations after Sevoflurane Anesthesia in Children. Anesthesiology. 84:348-353.. 1996
- 2005 The effect of delay in initiating radiotherapy post-lumpectomy on local breast recurrence. International Journal of Radiation Oncology Biology Physics. 36:280-280. 1996
- Low-Molecular-Weight Heparinoid Orgaran Is More Effective Than Aspirin in the Prevention of Venous Thromboembolism After Surgery for Hip Fracture. Circulation. 93:80-84. 1996
- Clinical trial design in metastatic breast cancer: a commentary.. The Canadian journal of oncology. 5 Suppl 1:40-42. 1995
- Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized Trials. New England Journal of Medicine. 333:1444-1456. 1995
- Hemorrhagic Complications of Anticoagulant Treatment. Chest. 108:276S-290S. 1995
- Hemorrhagic complications of anticoagulant treatment.. Chest. 108:276S-290S. 1995
- Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.. Chest. 108:291S-301S. 1995
- Prevention of Venous Thromboembolism. Chest. 108:312S-334S. 1995
- Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.. Journal of Clinical Oncology. 13:2386-2393. 1995
- P81 A trial evaluating the home treatment of patients with acute proximal deep vein thrombosis (DVT). Contemporary Clinical Trials. 16:118S-118S. 1995
- THROMBOLYTIC THERAPY FOR VENOUS THROMBOEMBOLISM. Clinics in Chest Medicine. 16:321-328. 1995
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin. New England Journal of Medicine. 332:1330-1336. 1995
- In response to Drs. Yaes and Yu. International Journal of Radiation Oncology Biology Physics. 32:552-553. 1995
- Breast irradiation postlumpectomy: development and evaluation of a decision instrument.. Journal of Clinical Oncology. 13:847-853. 1995
- Design and validation of a bedside decision instrument to elicit a patient's preference concerning allogenic bone marrow transplantation in chronic myeloid leukemia. American Journal of Hematology. 48:221-227. 1995
- The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation.. Journal of Clinical Oncology. 13:502-512. 1995
- Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis. Thrombosis and Haemostasis. 74:606-611. 1995
- The use of anti‐D to improve post‐transfusion platelet response: a randomized trial. British Journal of Haematology. 89:163-168. 1995
- Very low-dose warfarin prophylaxis to prevent thromboembolism in women with metastatic breast cancer receiving chemotherapy: an economic evaluation.. Journal of Clinical Oncology. 13:42-46. 1995
- Placebo-controlled randomized trial of infusional fluorouracil during standard radiotherapy in locally advanced head and neck cancer.. Journal of Clinical Oncology. 12:2648-2653. 1994
- Therapy-related leukemia associated with high-dose 4-epi-doxorubicin and cyclophosphamide used as adjuvant chemotherapy for breast cancer.. Journal of Clinical Oncology. 12:2514-2515. 1994
- Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery.. Circulation. 90:2385-2389. 1994
- Reduced Dose Bolus Alteplase vs Conventional Alteplase Infusion for Pulmonary Embolism Thrombolysis. Chest. 106:718-724. 1994
- Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Investigators of the Ontario Clinical Oncology Group.. International Journal of Radiation Oncology Biology Physics. 30:11-16. 1994
- Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. The Lancet. 343:886-889. 1994
- A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. JAMA Internal Medicine. 154:49-56. 1994
- Low molecular weight heparin: laboratory properties and clinical evaluation. A review.. British Journal of Surgery. 9-22. 1994
- Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty. ACP journal club. 119:1105-1105. 1993
- Adjuvant radiotherapy for early breast cancer: patterns of practice in Ontario.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 149:1273-1277. 1993
- Clinical Decision Making vs Programme Evaluation Perspectives. PharmacoEconomics (Auckland). 4:228-231. 1993
- Guidelines for clotting studies in cancer patients. For the Scientific and Standardization Committee of the Subcommittee on Haemostasis and Malignancy International Society of Thrombosis and Haemostasis.. Thrombosis and Haemostasis. 70:540-542. 1993
- Oral midazolam premedication in children: the minimum time interval for separation from parents. Canadian Journal of Anaesthesia. 40:726-729. 1993
- THE VALUE OF POSTOPERATIVE RED-CELL TRANSFUSIONS IS UNCLEAR - REPLY. Transfusion. 33:623-623. 1993
- The value of postoperative red cell transfusions is unclear. Transfusion. 33:622-623. 1993
- Smoking and Radiation Therapy for Head and Neck Cancer. New England Journal of Medicine. 328:1784-1785. 1993
- The physician as the patient's advocate. American Society of Clinical Oncology Committee of Patient Advocacy.. Journal of Clinical Oncology. 11:1011-1013. 1993
- The Head and Neck Radiotherapy Questionnaire: a morbidity/quality-of-life instrument for clinical trials of radiation therapy in locally advanced head and neck cancer.. Journal of Clinical Oncology. 11:863-872. 1993
- Thrombolytic therapy in acute pulmonary embolism.. Canadian Journal of Cardiology. 9:158-159. 1993
- Influence of Cigarette Smoking on the Efficacy of Radiation Therapy in Head and Neck Cancer. New England Journal of Medicine. 328:159-163. 1993
- A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer. European Journal of Cancer. 29:37-43. 1993
- Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer. European Journal of Cancer. 29:21-23. 1993
- Eliciting patient preferences.. ACP journal club. 118:76. 1993
- Guidelines for Clotting Studies in Cancer Patients. Thrombosis and Haemostasis. 70:540-542. 1993
- Limitations of Impedance Plethysmography in the Diagnosis of Clinically Suspected Deep-Vein Thrombosis. ACP journal club. 118:25-25. 1993
- Neuroleptic malignant syndrome in a child. Paediatric Anaesthesia. 3:47-50. 1993
- The Canadian Experience with Intensive Fluorouracil, Epirubicin and Cyclophosphamide in Patients with Early Stage Breast Cancer. Drugs. 45:51-59. 1993
- Hemostatic alterations in cancer patients. Cancer and Metastasis Reviews. 11:237-248. 1992
- A questionnaire to measure morbidity in patients receiving radiation therapy for head and neck cancer. Contemporary Clinical Trials. 13:389-389. 1992
- A randomized trial on the efficacy of an autologous blood drainage and transfusion device in patients undergoing elective knee arthroplasty. Transfusion. 32:742-746. 1992
- Hemorrhagic Complications of Anticoagulant Treatment. Chest. 102:352S-363S. 1992
- Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism. Chest. 102:364S-373S. 1992
- Hemorrhagic complications of anticoagulant treatment.. Chest. 102:352S-363S. 1992
- Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism.. Chest. 102:364S-373S. 1992
- Prevention of Venous Thromboembolism. Chest. 102:391S-407S. 1992
- Prophylactically equivalent doses of Enoxaparin and unfractionated heparin inhibit in vivo coagulation to the same extent. British Journal of Haematology. 82:400-405. 1992
- STANDARDIZATION OF HEPARIN-THERAPY IMPROVES EFFICACY - REPLY. Archives of Internal Medicine. 152:2143-2143. 1992
- Standardization of Heparin Therapy Improves Efficacy-Reply. JAMA Internal Medicine. 152:2413-2413. 1992
- A Low-Molecular-Weight Heparinoid Compared with Unfractionated Heparin in the Prevention of Deep Vein Thrombosis in Patients with Acute Ischemic Stroke. ACP journal club. 117:353-357. 1992
- A Bedside Decision Instrument To Elicit a Patient's Preference Concerning Adjuvant Chemotherapy for Breast Cancer. ACP journal club. 117:53-58. 1992
- Quality-of-Life Assessment: Patient Compliance With Questionaire Completion. Journal of the National Cancer Institute. 84:1023-1026. 1992
- The HER-2/neu oncogene in breast cancer: so what is new?. Journal of Clinical Oncology. 10:1034-1036. 1992
- Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy. Obstetrical and Gynecological Survey. 47:408-410. 1992
- Systemic Treatment of Early Breast Cancer by Hormonal, Cytotoxic, or Immune Therapy. Obstetrical and Gynecological Survey. 47:405-407. 1992
- Randomized Clinical Trial to Assess the Effectiveness of Breast Irradiation Following Lumpectomy and Axillary Disection for Node-Negative Breast Cancer. Journal of the National Cancer Institute. 84:683-689. 1992
- The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial. British Journal of Cancer. 65:737-743. 1992
- Thrombolytic therapy for the treatment of acute pulmonary embolism.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 146:1317-1324. 1992
- Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance. Thrombosis and Haemostasis. 67:639-643. 1992
- Low molecular weight heparin. Blood. 79:1-17. 1992
- The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation. British Journal of Cancer. 65:130-132. 1992
- Clinical Use of the Heparin Nomogram-Reply. JAMA Internal Medicine. 151:2321-2321. 1991
- Quality of life assessment: Patient compliance with questionnaire completion. Contemporary Clinical Trials. 12:708-709. 1991
- LMW Heparin for Deep Vein Thrombosis. ACP journal club. 115:231-232. 1991
- Bolus, front-loaded, and accelerated thrombolytic infusions for myocardial infarction and pulmonary embolism.. Chest. 99:128S-128S. 1991
- Prevention of Deep Vein Thrombosis after Elective Hip Surgery. ACP journal club. 114:545-551. 1991
- A standard heparin nomogram for the management of heparin therapy. JAMA Internal Medicine. 151:333-337. 1991
- Levamisole and 5-fluorouracil therapy for resected colon cancer: a new indication.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 144:297-301. 1991
- When is a prognostic factor useful? A guide for the perplexed.. Journal of Clinical Oncology. 9:348-356. 1991
- A Randomized Trial of a Single Bolus Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Acute Pulmonary Embolism. Chest. 98:1473-1479. 1990
- 15 Side-effects of antithrombotic therapy. Best Practice and Research in Clinical Haematology. 3:815-829. 1990
- 4 Clinical potential of low molecular weight heparins. Best Practice and Research in Clinical Haematology. 3:545-554. 1990
- A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.. Journal of Clinical Oncology. 8:1217-1225. 1990
- Risks to the Fetus of Anticoagulant Therapy during Pregnancy. Obstetrical and Gynecological Survey. 45:371-371. 1990
- A NEW SHORT INFUSION DOSAGE REGIMEN OF RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASE. Chest. 97:S168-S171. 1990
- A New Short Infusion Dosage Regimen of Recombinant Tissue Plasminogen Activator in Patients with Venous Thromboembolic Disease. Chest. 97:168S-171S. 1990
- A Randomized Trial of Less Intense Postoperative Warfarin or Aspirin Therapy in the Prevention of Venous Thromboembolism After Surgery for Fractured Hip. Survey of Anesthesiology. 34:85-85. 1990
- The diagnosis and treatment of thrombosis in the cancer patient.. Seminars in Oncology. 17:160-171. 1990
- Tissue Plasminogen Activator (rt-PA) vs Heparin in Deep Vein Thrombosis. Chest. 97:172S-175S. 1990
- Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.. Chest. 97:172S-175S. 1990
- Diagnosis of iron-deficiency anemia in the elderly. American Journal of Medicine. 88:205-209. 1990
- Use of screening phase data to evaluate observer variation of sputum cytodiagnosis as an outcome measure in a chemoprevention trial.. Cancer Research. 50:1216-1219. 1990
- Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.. Journal of Clinical Oncology. 8:203-208. 1990
- Chemoprevention for lung cancer--evidence for a high degree of compliance.. Cancer Epidemiology. 14:521-525. 1990
- Chemotherapy enhances endothelial cell reactivity to platelets. Clinical and Experimental Metastasis. 8:511-518. 1990
- Non-biological factors in day to day variation of heparin requirements.. The BMJ. 299:1012-1013. 1989
- Thromboembolic risk of tamoxifen in patients with stage II breast cancer.. Journal of Clinical Oncology. 7:1579-1580. 1989
- Recruitment for an efficacy study in chemoprevention—The concerned smoker study. Preventive Medicine. 18:700-710. 1989
- Etretinate Blood Levels in Monitoring of Compliance and Contamination in a Chemoprevention Trial. Journal of the National Cancer Institute. 81:795-798. 1989
- An overview of clinical trials of low molecular weight heparin fractions.. Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression. 30:347-348. 1989
- A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. JAMA Internal Medicine. 149:771-774. 1989
- HEMORRHAGIC COMPLICATIONS OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL-INFARCTION AND VENOUS THROMBOEMBOLISM. Chest. 95:S88-S97. 1989
- Hemorrhagic Complications of Long-term Anticoagulant Therapy. Chest. 95:26S-36S. 1989
- Hemorrhagic Complications of Thrombolytic Therapy in the Treatment of Myocardial Infarction and Venous Thromboembolism. Chest. 95:88S-97S. 1989
- Hemorrhagic complications of long-term anticoagulant therapy.. Chest. 95:26S-36S. 1989
- Optimal Therapeutic Range for Oral Anticoagulants. Chest. 95:5S-11S. 1989
- Optimal therapeutic range for oral anticoagulants [published erratum appears in Chest 1989 Oct;96(4):962]. Chest. 95:5S-11. 1989
- An Evaluation of Impedance Plethysmography and 125I-Fibrinogen Leg Scanning in Patients following Hip Surgery. Thrombosis and Haemostasis. 62:830-834. 1989
- Prevention of venous thrombosis in patients undergoing major orthopaedic surgical procedures.. International Journal of Clinical Practice, Supplement. 65:2-8. 1989
- Responsiveness and validity in health status measurement: A clarification. Journal of Clinical Epidemiology. 42:403-408. 1989
- Risks to the Fetus of Anticoagulant Therapy During Pregnancy. Thrombosis and Haemostasis. 61:197-203. 1989
- The Relationship between Anti-Factor Xa Level and Clinical Outcome in Patients Receiving Enoxaparine Low Molecular Weight Heparin to Prevent Deep Vein Thrombosis after Hip Replacement. Thrombosis and Haemostasis. 62:940-944. 1989
- Quality of life in stage II breast cancer: an instrument for clinical trials.. Journal of Clinical Oncology. 6:1798-1810. 1988
- Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.. Journal of Clinical Investigation. 82:1700-1707. 1988
- Adjuvant Therapy for Breast Cancer. New England Journal of Medicine. 319:443-446. 1988
- Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial.. Journal of Clinical Oncology. 6:963-968. 1988
- The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer. New England Journal of Medicine. 318:404-407. 1988
- An overview of clinical trials of low molecular weight heparin fractions.. British Journal of Surgery. 543:73-79. 1988
- Clinical Use of Low Molecular Weight Heparins and Heparinoids. Seminars in Vascular Medicine. 14:116-125. 1988
- Confusion Over the Therapeutic Range for Monitoring Oral Anticoagulant Therapy in North America. Thrombosis and Haemostasis. 59:129-132. 1988
- The optimal intensity of oral anticoagulant therapy. Journal of the American Medical Association (JAMA). 258:2723-2726. 1987
- Adjusted Subcutaneous Heparin or Continuous Intravenous Heparin in Patients with Acute Deep Vein Thrombosis. ACP journal club. 107:441-441. 1987
- A Randomized Controlled Trial of Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery. Survey of Anesthesiology. XXXI:225-225. 1987
- Low-Molecular-Weight Heparin and Deep-Vein Thrombosis. New England Journal of Medicine. 316:949-949. 1987
- DOUBLE-BLIND RANDOMISED TRIAL OF ORG 10172 LOW-MOLECULAR-WEIGHT HEPARINOID IN PREVENTION OF DEEP-VEIN THROMBOSIS IN THROMBOTIC STROKE. The Lancet. 329:523-526. 1987
- Sample Size in the Planning and Interpretation of Clinical Trials. Thrombosis and Haemostasis. 58:953-956. 1987
- Treatment of First Episode of Venous Thrombosis. Advances in Experimental Medicine and Biology. 214:187-193. 1987
- Bench-to-bedside research and the human tumor stem-cell assay--bridging the credibility gap.. Journal of Clinical Oncology. 4:1730-1731. 1986
- DOSE INTENSITY AND RESPONSE - REPLY. Journal of Clinical Oncology. 4:1865-1865. 1986
- Therapeutic Range for the Control of Oral Anticoagulant Therapy. JAMA Neurology. 43:1162-1164. 1986
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery. New England Journal of Medicine. 315:925-929. 1986
- Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.. Journal of Clinical Oncology. 4:1162-1170. 1986
- HEMORRHAGIC COMPLICATIONS OF LONG-TERM ANTICOAGULANT-THERAPY. Archives of Internal Medicine. 146:466-466. 1986
- Hemorrhagic Complications of Long-term Anticoagulant Therapy. Chest. 89:16S-25S. 1986
- Hemorrhagic complications of long-term anticoagulant therapy.. Chest. 89:16S-25S. 1986
- Heroin vs morphine for cancer pain?. JAMA Internal Medicine. 146:353-356. 1986
- Pleural effusion in breast cancer. Thoracoscopy for hormone receptor determination. Cancer. 57:324-327. 1986
- A CRITICAL-APPRAISAL OF THE USE OF ANTICOAGULANT-THERAPY - EFFECTIVENESS, MONITORING, AND COMPLICATIONS - PREFACE. Seminars in Thrombosis and Hemostasis. 12:U1-U1. 1986
- Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer.. Journal of the National Cancer Institute. Monographs. No. 1:87-94. 1986
- Hemorrhagic Complications of Anticoagulant Therapy. Seminars in Vascular Medicine. 12:39-57. 1986
- Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.. Stroke. 17:111-116. 1986
- Heparin-Induced Thrombocytopenia. Seminars in Vascular Medicine. 12:59-62. 1986
- Nonhemorrhagic Complications of Anticoagulant Therapy. Seminars in Vascular Medicine. 12:63-66. 1986
- Risks and Benefits of Anticoagulant Therapy. Seminars in Vascular Medicine. 12:67-71. 1986
- Survival results from a phase III study of simultaneous versus 1‐hour sequential methotrexate—5‐fluorouracil chemotherapy in head and neck cancer. Head and Neck. 8:146-152. 1986
- Cost-effectiveness in the diagnosis and treatment of carcinoma of unknown primary origin.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 133:977-987. 1985
- Risk of Haemorrhage Associated with Long Term Anticoagulant Therapy. Drugs. 30:444-460. 1985
- Untreated Low-Grade Non-Hodgkin's Lymphoma. New England Journal of Medicine. 312:1191-1192. 1985
- ACUTE VINCRISTINE NEUROTOXICITY. The Lancet. 325:346-346. 1985
- Acquired alteration in the expression of blood groups in a patient with sideroblastic anemia and chronic renal failure. Transfusion. 24:8-12. 1984
- Detection of radiation cardiomyopathy by gated radionuclide angiography. American Journal of Medicine. 75:928-IN1. 1983
- Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.. Journal of Clinical Oncology. 1:787-792. 1983
- Phenotypic characterization of human bone marrow granulocyte-macrophage forming progenitor cells. Blood. 58:1047-1049. 1981
preprints